Prof Borislava (Boby) Mihaylova

Boby Mihaylova is Professor of Health Economics and Lead of the Health Economics and Policy Research Unit at the Wolfson Institute of Population Health, QMUL. Her expertise lies across the areas of health economics and health technology assessment and includes primary and evidence synthesis research.  She has a particular interest in developing evaluative frameworks using individual people data to inform more targeted policy decisions.

Boby leads research on impact of diseases and treatments on morbidity, mortality, health-related quality of life and healthcare/other resources and costs; cost-effectiveness of prevention and treatment strategies; and development of evaluative frameworks and disease models to assess net effects of policies and treatments. Her work includes applied and methodological research across high burden disease areas aiming to contribute robust evidence that reliably informs national and international health policy.

Boby is a co-director of the Wellcome Trust PhD Programme in Science “Health data in practice: human-centred science”, co-leads the MSc module “Health Economic Analyses” and is a member of the European Society of Cardiology Clinical Guidelines Committee and Value in Health’s Editorial Board.